Muse Bio is a biotechnology research centre that transforms menstrual blood into renewable mesenchymal stem cells.
Muse Bio has raised $1.1M in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2026.
Muse Bio's investors include Draper Associates, Boost VC.
Muse Bio is headquartered in San Francisco, United States.
Muse Bio is a biotechnology research centre that transforms menstrual blood into renewable mesenchymal stem cells.
Muse Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Muse Bio — Funding & Investors." VCBacked, January 1, 2026, https://www.vcbacked.co/company/muse-bio. Accessed July 19, 2026.
VCBacked. (2026). Muse Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/muse-bio
{{cite web |title=Muse Bio — Funding & Investors |url=https://www.vcbacked.co/company/muse-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated